Previous Article | Next Article ![]()
Molecular and Cellular Biology, January 2003, p. 38-54, Vol. 23, No. 1
0270-7306/03/$08.00+0 DOI: 10.1128/MCB.23.1.38-54.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Protein Has a Role in Embryogenesis and Gametogenesis
Ottawa Regional Cancer Centre and Department of Medicine, University of OttawaOttawa, Ontario K1H 1C4,1 Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa K1H 8M5,3 Terry Fox Laboratory, British Columbia Cancer Research Center, and Department of Medicine, University of British Columbia, Vancouver, British Columbia V5Z 1L3, Canada,4 Department of Pathology, Brown University, Providence, Rhode Island 029122
Received 3 July 2002/ Returned for modification 4 September 2002/ Accepted 1 October 2002
| ABSTRACT |
|---|
|
|
|---|
, is the presumptive mammalian homologue of the yeast sir2 gene. We set out to determine if sir2
plays a role in mammalian gene silencing by creating a strain of mice carrying a null allele of sir2
. Animals carrying two null alleles of sir2
were smaller than normal at birth, and most died during the early postnatal period. In an outbred background, the sir2
null animals often survived to adulthood, but both sexes were sterile. We found no evidence for failure of gene silencing in sir2
null animals, suggesting that either SIR2
has a different role in mammals than it does in Saccharomyces cerevisiae or that its role in gene silencing in confined to a small subset of mammalian genes. The phenotype of the sir2
null animals suggests that the SIR2
protein is essential for normal embryogenesis and for normal reproduction in both sexes. | INTRODUCTION |
|---|
|
|
|---|
Sir2p has NAD+-dependent histone deacetylase activity (18, 24, 43, 45), and the catalytic domain of Sir2p is present in four other genes in S. cerevisiae (10). This domain is also present in genes encoded by the genomes of the most primitive organisms (7) as well as in mammals (13). Seven mammalian genes carry the SIR2 catalytic domain, and this domain can substitute for the same domain in yeast Sir2p (42).
Yeast Sir2p plays an important role not only in gene silencing but also in a variety of other biological processes. These include regulation of the cell cycle, DNA repair, DNA recombination, and aging (reviewed in references 14, 17, and 33).
Given the extraordinary conservation of the SIR2 catalytic domain and the multitude of biological functions served by the yeast Sir2p, it seems likely that the related proteins in mammalian cells also have important functions. We were particularly interested in determining whether the mammalian sir2 homologues play roles in gene silencing. We therefore selected the murine gene most closely related to the yeast SIR2 and created a null allele of this sir2
gene in embryonic stem (ES) cells. This null allele was introduced into the germ line of mice, and sir2
null animals were created. The characteristics of these mice suggest that the mammalian SIR2
protein has no role in gene silencing but plays a role in the growth and maturation of the embryo and in gametogenesis in both sexes.
| MATERIALS AND METHODS |
|---|
|
|
|---|
|
Vaginal washes from female animals were acquired daily and assessed essentially as described previously (47). The females were maintained in cages that had previously been occupied by males.
Blot hybridization. DNA was isolated from cells or tissues by standard procedures (23), digested with restriction enzymes under the conditions recommended by the manufacturer, and separated by electrophoresis on 1% agarose gels (41). The DNA was transferred to membranes, radioactive probes were created by oligonucleotide priming from isolated DNA fragments, and hybridization was carried out as described previously (41). RNA isolation, gel electrophoresis, and blot hybridization were done as described previously (41).
Immunofluorescence.
Immunofluorescence was performed on whole preimplantation embryos or frozen sections from adult or embryonic tissues previously fixed for 1 to 2 h in 4% paraformaldehyde. Rabbit antiserum directed against the SIR2
protein (M.W. McBurney, X. Yang, K. Jardine, M. Bieman, J. Thng, and M. Lemieux, unpublished data) was immunopurified by adsorption and elution from recombinant His-tagged SIR2
protein made in bacteria. After incubation with the primary and secondary antibodies, preparations were stained with Hoechst 33258 before mounting and viewing in a Zeiss Axiophot microscope equipped with a deconvolution system.
| RESULTS |
|---|
|
|
|---|
gene structure and targeted disruption.
Although there are seven genes in the human (16) and mouse genomes that share a region homologous to the catalytic domain of the yeast SIR2 gene, one of these homologues, sir2
, encodes a protein with a higher degree of sequence identity (40%) to the yeast Sir2p than the other six. The full-length cDNA sequence of sir2
has been published (18). We amplified a partial sir2
cDNA encoding the C terminus of the SIR2
protein from reverse-transcribed mRNA isolated from the R1 line of ES cells (36). This sir2
cDNA was used to screen a bacteriophage genomic library derived from the DNA from strain 129/Sv mice (a gift from Douglas Gray). Two overlapping clones were isolated, subcloned into plasmid vectors, restriction mapped, and partially sequenced. The cloned genomic region consisted of the last seven exons of the sir2
gene (Fig. 1), a gene structure that is the same as that of its human homologue (accession number AL133551).
We constructed two knockout vectors designed to delete exons 5 and 6 from the sir2
gene. These two exons encode a region of the SIR2
protein that comprises a large portion of the catalytic domain, so we predicted that the result of homologous recombination would be a null sir2
allele. Because the sir2
gene is expressed in ES cells (McBurney et al., unpublished data), we created a knockout vector in which the selectable gene encoding hygromycin resistance would be driven by the sir2
promoter following homologous integration into the sir2
locus (35) (see Fig. 1). This vector was linearized and electroporated into R1 cells. Treated cells were selected in hygromycin, and drug-resistant colonies were expanded and screened by Southern blot hybridization with probes that identify both the 5' and 3' sides of the homologous recombination event.
A second knockout vector was created with the selectable gene encoding G418 resistance (35) inserted into the same sir2
targeting arms, and this linearized vector was electroporated into one of the R1 clones carrying the correctly targeted hygromycin resistance vector. Cells resistant to G418 were selected and expanded for analysis. Among the G418-resistant clones were those in which both wild-type alleles of sir2
were replaced with the two knockout vectors (Fig. 2). These sir2
null cells grew well in culture and have been maintained for more than a year, indicating that the SIR2
protein is not essential for cell growth, viability, or immortality.
|
protein. To confirm this, we created a polyclonal rabbit antibody that recognizes the murine SIR2
protein (McBurney et al., unpublished data) and used this antibody to probe protein blots from the ES knockout cells (Fig. 3). ES cells carrying one knockout allele had approximately half the SIR2
protein present in the diploid wild-type cells, and the double knockout had no detectable SIR2
protein.
|
null allele into both the outbred CD1 line and the inbred 129/Sv strain. Animals carrying the sir2
null allele were identified by Southern blot hybridization, and these heterozygous animals were fertile and apparently normal.
sir2
null genotype is postnatal lethal.
Males and females heterozygous for the sir2
null allele were mated, and offspring were genotyped at weaning by Southern blotting (Fig. 4). Animals carrying two sir2
null alleles were present among the viable offspring, but their proportion was about half what was expected, suggesting that there was prenatal or early postnatal loss of approximately half of the sir2
null offspring.
|
null embryos during gestation, we mated heterozygous animals and harvested mothers at various times after the appearance of the copulation plug. Each embryo was genotyped from DNA isolated from the fetal membranes, and each embryo was fixed for examination. sir2
null embryos were present at early and late stages of gestation in roughly the expected proportions, but some of these sir2
null embryos were abnormal (Fig. 5) and would not have survived following birth. Thus, the reduced number of sir2 null animals at birth probably reflects the immediate postnatal loss of abnormal fetuses.
|
null embryos looked normal but were smaller than their wild-type or heterozygous littermates (Fig. 5). Examination of some of the sir2
null fetuses indicated that they were retarded in certain developmental processes. For example, the mineralization of the digits in the sir2 null animals was delayed relative to their wild-type littermates (K. Reuhl et al., unpublished observations).
Following birth, the sir2
null mice were easily identified, as they were smaller than their littermates and their subsequent development was slower than that of their littermates. The most obvious developmental delay was eyelid opening. In the sir2
null animals, eyelids remained closed forever or for several months after birth.
The postnatal development of the sir2
null animals was dependent on their genetic background. On the inbred 129/Sv genetic background, the sir2
null animals invariably died before reaching 1 month of age. On the outbred genetic background from a mix of the CD1 and 129/Sv strains, the sir2
null mice were much more likely to thrive, although their stature was smaller than that of their littermates (Fig. 6) and they all had the characteristic eyelid defect. Many of these sir2
null animals had a short or deviated snout as well but otherwise appeared normal. During the early postnatal period, these sir2
null animals were inevitably smaller than their littermates, but most thrived and eventually approached the size of the wild-type animals (Fig. 7).
|
|
null mice do not open in a timely manner. Two organs consistently affected in the mutants were the lung and pancreas. Neutrophil infiltration of the lungs suggested chronic pulmonary infection that led to pneumonitis, pulmonary edema, and right ventricular hypertrophy. The pancreas showed patchy atrophy of the exocrine epithelium. These lung infections and pancreatic defects are probably responsible for the early postnatal lethality of the sir2
null animals. An examination of the lymphoid system in sir2
null animals indicated that the thymus contained normal numbers and proportions of T cells and that the spleen complement of B cells was normal. The only consistent abnormality appeared to be a reduced proportion of CD8-positive T cells in the spleens of sir2
null animals.
sir2
null animals do not reexpress a silenced transgene or prematurely erode their telomeres.
The yeast Sir2p is essential for maintaining the transcriptional inactivity of genes in this organism. The fact that the sir2
null mice develop relatively normally and that a very large proportion of the genes in a mammalian tissue remain silent suggest that the mammalian SIR2
may not be required to maintain gene inactivity in the mammalian genome. We probed Northern blots of RNA isolated from sir2
null and wild-type day-12.5 embryos and adult tissues. These blots yielded no evidence for ectopic expression of any of the endogenous genes that we assayed (IGF-II, IGF-IIR, endogenous retrovirus, gtl-2, SNRPN, Peg-3, H19, Lo-1, Zfp127, necdin, UBE3, and ß2-microglobulin). Microarray analysis of RNA isolated from day-12.5 embryos also indicated that the vast majority of genes are normally expressed in the sir2
null animals.
Nevertheless, we set out to directly test whether the inactivation of a silent transgene could be modulated in sir2
null animals. For this experiment, we used a previously described transgenic strain of mice that carry eight copies of a transgene consisting of the regulatory sequences of the mouse Pgk-1 gene driving the Escherichia coli lacZ reporter sequence (32). This Pgk-1,2-lacZ transgene is expressed in all tissues investigated and encodes a fusion protein with ß-galactosidase activity.
The Pgk-1,2-lacZ transgene remains active provided it is inherited through the male germ line; however, if this transgene is inherited through the female germ line, its expression is irreversibly abolished (26). We interbred female mice carrying the sir2
null allele with male animals carrying the active Pgk-1,2-lacZ transgene. Animals heterozygous for the sir2
null allele were mated with each other so that the Pgk-1,2-lacZ gene was inherited from either the male or the female parent. Embryos were harvested at 9.5 days of gestation, each embryo was fixed and stained for ß-galactosidase expression, and the fetal membranes of each embryo were used to isolate DNA, from which the genotype of each embryo was determined.
Embryos who inherited their Pgk-1,2-lacZ transgene from the male parent expressed ß-galactosidase as determined by the 5-bromo-4-chloro-3-indolyl-ß-D-galactopyranoside (X-Gal) staining of these embryos (Fig. 8D). Embryos that inherited their Pgk-1,2-lacZ transgene from the female parent are expected to inherit this transgene in an inactive form. It is evident that the embryos shown in Fig. 8A, numbers 1, 8, and 9, have inherited the Pgk-1,2-lacZ transgene along with at least one wild-type copy of sir2
. As expected, these embryos failed to express the transgene, as indicated by the absence of X-Gal staining. The embryos labeled 4 and 7 also inherited the Pgk-1,2-lacZ transgene, but these two embryos were also sir2
null. Because neither embryo 4 nor 7 was stained with X-Gal, we conclude that the absence of SIR2
did not result in compromised repression of the silent Pgk-1,2-lacZ transgene.
|
null animals that had inherited the Pgk-1,2-lacZ transgene from their mothers did not express it, while the sir2
null animals that inherited the Pgk-1,2-lacZ transgene from their fathers did show staining with X-Gal in their internal tissues. Thus, the sir2
null animals did not express the silenced transgenes or modulate the expression of active transgenes.
The yeast Sir2p also plays a role in determining the rate at which yeast mother cells undergo senescence (20). Work with Caenorhabditis elegans also suggests that the sir2 homologue in worms may also play a similar role in regulating aging (46). Because many of the sir2
null animals died before weaning, one possibility is that they are aging prematurely. To investigate this possibility, we compared the lengths of the telomeres in both B and T lymphocytes from wild-type and sir2
null littermates with animals of 4 months of age on the outbred CD1 background. The mean telomere lengths in these cells were identical (Fig. 9). In addition, the chromosomes from the cells appeared normal, consistent with the absence of telomere erosion that might be predicted to occur if the sir2
null animals underwent premature aging. Our oldest sir2
null animals are now 17 months old.
|
expression is widespread, but the protein is associated with euchromatin.
To attempt to understand the phenotype of the sir2
null mice, we investigated the normal expression pattern of the sir2
gene by probing Northern blots of RNA isolated from various tissues. The sir2
transcript was readily detected in all tissues investigated (Fig. 10) and was particularly evident in the testis and ovary.
|
protein (McBurney et al., unpublished data) was used for immunoblots of protein isolated from various murine tissues and to carry out immunofluorescence studies on these tissues. Despite the prevalence of the sir2
transcript in adult mouse tissues, we were able to detect protein only in the testis and ovary (see below).
We had noted previously that the SIR2
protein is expressed in abundance in embryonal carcinoma and embryonic stem cells (McBurney et al., unpublished data), so we carried out immunofluorescence experiments in early embryonic cells. The SIR2
protein was present and easily detected in zygotes, two-cell embryos (Fig. 11), and cells of the blastocyst. At all stages, the distribution of the SIR2
protein was nuclear, but it was not concentrated in those regions of the nucleus thought to contain heterochromatin and identified by intense staining with DNA intercalating dyes such as Hoechst 33258. SIR2
also appeared to be excluded from the nucleolus. There was no staining with this antibody in cells from embryos that were sir2
null (data not shown), consistent with the prediction that no stable protein could be made from the knockout allele.
|
protein was evident in large oocytes as well as in proliferating granulosa cells in larger follicles (Fig. 12). Within both cell types, the SIR2 protein was nuclear and the intranuclear distribution was similar to that seen in early embryonic cells; the protein was nuclear but appeared to be associated with the euchromatin rather than the heterochromatin.
|
protein was present in the nuclei of spermatogenic cells only (Fig. 13). In the developmental sequence of germ cells, a weak, finely speckled nuclear staining was observed in type A spermatogonia, while type B and intermediate spermatogonia displayed a slightly more intense nuclear staining with coarser positive spots. Spermatocytes and round spermatids were intensely positive with diffusely speckled nuclear staining. Soon after the spermatids began to elongate (step 9), the nuclear staining decreased to only a few spots and by step 11 was lost altogether. This staining pattern identifies the nuclear localization of the SIR2 protein in late spermatogonia, spermatocytes, and round spermatids, with the main expression in pachytene spermatocytes. There was no staining of Sertoli cells or of peritubular cells. Due to inherent autofluorescence, the staining of Leydig cells could not be assessed.
|
knockout mice are sterile.
Although many sir2
null mice died before reaching maturity, some of those on the outbred background did survive, and these mature animals were caged with wild-type animals of the opposite sex. Both male and female sir2
null animals were sterile. Eleven sir2
null male animals were caged with wild-type females for up to 6 months (mean, 4 months), and none has sired a single litter despite evidence of copulation plugs in a number of the female mates. Seven sir2
null female animals were caged with wild-type males for up to 7 months (mean, 3.5 months). Only one of these females was fertile. She produced three litters but failed to suckle her offspring. However, some of these pups were fostered to another mother, with whom they were able to suckle and thrive and develop into fertile males and females.
The female reproductive tract in sir2
null animals was characterized by small ovaries in which the corpora lutea were conspicuously absent and the uterus was thin walled. Microscopic examination indicated that early, intermediate, and late stages of follicle development were present, but the absence of the corpus luteum indicated that ovulation did not occur. We examined the vaginal washes from two sir2
null females and two wild-type females maintained for 18 days in cages previously occupied by males. The wild-type females cycled through estrus every 4 to 6 days, but the sir2
null animals appeared to be arrested in diestrus. To determine if the absence of an estrous cycle was the cause of the infertility, we injected two sir2
null and two wild-type animals with hormones (5 IU of pregnant mare serum gonadotropin followed 46 h later with 5 IU of human choriogonadotropin) to induce ovulation. The next day, ovulated eggs were present in the oviducts of both sir2
null animals (16 and 19 eggs) as well as in both wild-type animals (29 and 35 eggs). This is consistent with the idea that female sterility in the sir2
null animals is due to hormonal inadequacy.
Analysis of spermatozoa from the cauda epididymis of wild-type and sir2
null mice showed striking differences in number, appearance, and motility. Wild-type mice had sperm counts of 48.8 x 106 ± 12.4 x 106, whereas the sir2
null animals had dramatically reduced numbers of mature sperm, with average counts of 2.6 x 106 ± 3.6 x 106 (data from three animals of each genotype). Virtually none of the sperm from the sir2
null mice were motile. Wild-type spermatozoa cell bodies had a consistent shape with a characteristic hook (Fig. 14a). In contrast, the majority of the sperm of the sir2
null mice were abnormal, with small, rounded, or smudged cell bodies and blunted or absent hooks (Fig. 14b). In addition, many of the sperm from sir2
null mice had retained cytoplasm around the nucleus, and many of the flagella appeared very fine and had no cell body attached.
|
null mice were subnormal in weight (wild type, 0.087 ± 0.013 g, n = 3; sir2 null, 0.056 ± 0.011 g, n = 3). Flow cytometry of testicular cells stained for DNA content indicated that all stages of spermatogenesis were present (Fig. 15), but a histological inspection indicated that the spermatogenesis occurring in the testes of sir2
null mice was abnormal. In the least affected testis, only subtle evidence of abnormal spermatogenesis was apparent, manifested as an increased incidence of spermatocyte apoptosis, occasional multinucleated germ cells, decreased numbers of mature elongated spermatids, and increased numbers of retained elongated spermatids.
|
|
deacetylase activity, that p53 activity is dependent on acetylation, and that p53 function is normally modulated by SIR2
deacetylation (25, 29, 50). Apoptosis in the testis is dependent on p53 (4, 8, 52), and therefore the elevated frequency of apoptotic cells might be a consequence of the absence of SIR2
in the testes of sir2
null animals. We also predicted that the testes of the sir2
null mice might be hypersensitive to radiation. Wild-type and sir2
null mice were irradiated with 3 Gy and sacrificed 12 h later, and seminiferous tubules were examined for their incidence of apoptosis. X-irradiation increased the frequency of apoptotic cells in the testes of both wild-type and sir2
null mice (Fig. 17). However, testes from the the sir2
null mice did not appear to be hypersensitive to the radiation.
|
| DISCUSSION |
|---|
|
|
|---|
were required for the maintenance of gene silencing, we would expect that the sir2
null animals would die very early during embryogenesis as a consequence of ectopic expression of genes normally maintained in an inactive state. The relatively mild phenotype of these null animals suggests that the SIR2
protein is not involved in the global silencing of genes in the mammalian genome, and this was partly confirmed by the normally regulated expression of a number of individual genes assessed both on Northern blots and in microarray assays. We directly tested the role of SIR2
in maintaining the inactivity of a silent transgene and found that the lack of expression of the transgene was not influenced by the sir2
genotype. Additional studies with sir2
null ES cells also indicated that these cells were not compromised in their ability to establish or maintain genes in their inactive state (McBurney et al., unpublished data).
Immunolocalization of the SIR2
protein to the euchromatin of mammalian cells is also consistent with the idea that this protein plays a role different from that of the yeast Sir2p. The Drosophila homologue of SIR2 is also associated with active genes and euchromatin (48), although it appears to be required for the downregulation of certain genes (40). The yeast Sir2p is not localized only to inactive regions of the genome such as the telomere; it is also found in multiprotein complexes that can be isolated as large stable assemblages (15). The Drosophila SIR2p is not found in a large complex but can be isolated in native conditions in a 200-kDa fraction, perhaps as a dimer (6). The mouse SIR2
protein runs on gel filtration columns at about 160 kDa, a size consistent with its being a dimer and not a member of a large multiprotein complex (McBurney et al., unpublished data).
The yeast Sir2p is part of a complex of proteins that associates with chromatin in regions that are maintained transcriptionally inert. The histone deacetylase activity of Sir2p is essential for the proper function of these protein complexes, and the substrate is thought to be the N termini of core histones. In mammals, a large number of nuclear proteins in addition to histones are acetylated (44), and in the cases of some important nuclear proteins such as retinoblastoma (11) and p53 (38, 51), it is thought that acetylation plays a role in regulating the function of these transcription regulators. In fact, there is evidence from transfection experiments suggesting that p53 is a substrate for SIR2
and that deacetylation of p53 downregulates its transactivation function (25, 29, 50). If SIR2
were part of the network regulating p53 activity, one might predict that the sir2
null mice would have hyperactive p53. Our finding that the testes of sir2
null mice have high spontaneous levels of apoptosis is consistent with this idea.
The reproductive viability of yeast mother cells is regulated by Sir2p (20), and the prolongation of cell viability brought about by caloric restriction is dependent on the presence of Sir2p (27). This effect of Sir2p is thought to be due to its ability to suppress recombination between tandem copies of the ribosomal genes, as aging mother cells show loss of ribosomal DNA, presumed to be due to recombinational excision from the genome (20). In S. cerevisiae, extra copies of the sir2 gene extend the life span of yeast mother cells. In C. elegans, an extra copy of the sir2 gene also resulted in extended life spans (46), but the evidence from this organism suggests that this effect of Sir2p acts via a mechanism unrelated to gene silencing or suppression of recombination. It appears that in C. elegans, Sir2p is part of the insulin-like growth factor signaling pathway, and the hyperactivity of this pathway forestalls normal aging.
The involvement of Sir2p in growth factor signaling in C. elegans might be an important clue to the role of SIR2
in mammalian cells. The phenotype of the sir2
null mice that we described above is strikingly similar to the phenotypes of mice bearing null alleles of IGF-1, IGF-2, and IGF-2R (1, 5, 12, 28, 37). The shared phenotypes include infertility, retarded growth rates, reduced survival to adulthood, reduced adult weight, and slowed rates of bone mineralization. The levels of expression of IGF-2 and IGF-2R are the same in wild-type and sir2
null animals (unpublished results), consistent with the genetic results from C. elegans that indicate that Sir2p is downstream of the growth factor in the pathway. The phenocopy of null alleles does not necessarily imply that SIR2
is in the IGF signaling pathway; for example, mice null for the activin ßB gene also have reproductive and eyelid opening defects, similar to the sir2
null mice (49).
The reproductive defects in the two sexes are nicely correlated with the fact that gonads from the two sexes are the only adult tissues expressing detectable amounts of the SIR2
protein. However, the defects in the two sexes seem to be caused by different SIR2
-mediated effects. In females, oocytes appear to mature normally but fail to be ovulated. Female animals do not appear to cycle efficiently through estrus, perhaps indicating a hormonal defect. Granulosa cells are important sources of and responders to the hormones responsible for ovulation, and granulosa cells normally express high levels of the SIR2
protein. It is perhaps pertinent that IGF signaling occurs in granulosa cells (21, 34), and the hypothesized role of SIR2
in this pathway may be responsible for the defect in ovulation.
Infertility in male sir2
null animals appears to be due to inefficient spermatogenesis and the failure of sperm to mature properly. SIR2
is expressed in all stages of sperm development and disappears only during the late stages of nuclear condensation. However, it is these late stages that appear to be particularly defective, perhaps indicating that the spermatogenesis defect is in part mediated by a systemic problem. This is consistent with the observation that most of the sex organs are smaller in sir2
null animals than in their wild-type littermates.
The early postnatal lethality of sir2
null animals is difficult to reconcile with the observation that the SIR2
protein seems to be abundantly expressed only during early development and becomes undetectable in somatic tissues from midgestation on. It is possible that the SIR2
protein is expressed in mature somatic tissues at levels below the limit of detection of our antibody or that its expression is tightly regulated at the posttranscriptional level (the sir2
mRNA is readily detected in all somatic tissues tested). Alternatively, the absence of SIR2
during early embryogenesis may set in motion events whose legacy is not felt until much later during development. Were the SIR2
protein involved in the IGF signaling pathway, one might envisage how its absence might contribute to unbalanced tissue growth during early embryogenesis and subsequent failure of those tissues at later developmental times.
| ACKNOWLEDGMENTS |
|---|
This work was supported by the National Cancer Institute of Canada and the Canadian Institutes of Health Research.
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
2. Adra, C. N., P. H. Boer, and M. W. McBurney. 1987. Cloning and expression of the mouse pgk-1 gene and the nucleotide sequence of its promoter. Gene 60:65-74.[CrossRef][Medline]
3. Adra, C. N., N. A. Ellis, and M. W. McBurney. 1988. The family of mouse phosphoglycerate kinase genes and pseudogenes. Somat. Cell Mol. Genet. 14:69-81.[CrossRef][Medline]
4. Allemand, I., A. Anglo, A. Y. Jeantet, I. Cerutti, and E. May. 1999. Testicular wild-type p53 expression in transgenic mice induces spermiogenesis alterations ranging from differentiation defects to apoptosis. Oncogene 18:6521-6530.[CrossRef][Medline]
5. Baker, J., J. P. Liu, E. J. Robertson, and A. Efstratiadis. 1993. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75:73-82.[CrossRef][Medline]
6. Barlow, A. L., C. M. van Drunen, C. A. Johnson, S. Tweedie, A. Bird, and B. M. Turner. 2001. dSIR2 and dHDAC6: two novel, inhibitor-resistant deacetylases in Drosophila melanogaster. Exp. Cell Res. 265:90-103.[CrossRef][Medline]
7. Bell, S. D., C. H. Botting, B. N. Wardleworth, S. P. Jackson, and M. F. White. 2002. The interaction of Alba, a conserved archaeal chromatin protein, with Sir2 and its regulation by acetylation. Science 296:148-151.
8. Beumer, T. L., H. L. Roepers-Gajadien, I. S. Gademan, P. P. van Buul, G. Gil-Gomez, D. H. Rutgers, and D. G. de Rooij. 1998. The role of the tumor suppressor p53 in spermatogenesis. Cell Death Differ. 5:669-677.[CrossRef][Medline]
9. Bird, A. 2002. DNA methylation patterns and epigenetic memory. Genes Dev. 16:6-21.
10. Brachmann, C. B., J. M. Sherman, S. E. Devine, E. E. Cameron, L. Pillus, and J. D. Boeke. 1995. The SIR2 gene family, conserved from bacteria to humans, functions in silencing, cell cycle progression, and chromosome stability. Genes Dev. 9:2888-2902.
11. Chan, H. M., M. Krstic-Demonacos, L. Smith, C. Demonacos, and N. B. La Thangue. 2001. Acetylation control of the retinoblastoma tumour-suppressor protein. Nat. Cell Biol. 3:667-674.[CrossRef][Medline]
12. Chinnadurai, G. 2002. CtBP, an unconventional transcriptional corepressor in development and oncogenesis. Mol. Cell 9:213-224.[CrossRef][Medline]
13. Frye, R. A. 2000. Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem. Biophys. Res. Commun. 273:793-798.[CrossRef][Medline]
14. Gasser, S. M., and M. M. Cockell. 2001. The molecular biology of the SIR proteins. Gene 279:1-16.[CrossRef][Medline]
15. Ghidelli, S., D. Donze, N. Dhillon, and R. T. Kamakaka. 2001. Sir2p exists in two nucleosome-binding complexes with distinct deacetylase activities. EMBO J. 20:4522-4535.[CrossRef][Medline]
16. Gray, S. G., and T. J. Ekstrom. 2001. The human histone deacetylase family. Exp. Cell Res. 262:75-83.[CrossRef][Medline]
17. Guarente, L. 2000. Sir2 links chromatin silencing, metabolism, and aging. Genes Dev. 14:1021-1026.
18. Imai, S., C. M. Armstrong, M. Kaeberlein, and L. Guarente. 2000. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403:795-800.[CrossRef][Medline]
19. Jenuwein, T., and C. D. Allis. 2001. Translating the histone code. Science 293:1074-1080.
20. Kaeberlein, M., M. McVey, and L. Guarente. 1999. The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev. 13:2570-2580.
21. Khamsi, F., S. Roberge, Y. Yavas, I. C. Lacanna, X. Zhu, and J. Wong. 2001. Recent discoveries in physiology of insulin-like growth factor-1 and its interaction with gonadotropins in folliculogenesis. Endocrine 16:151-165.[CrossRef][Medline]
22. Kouzarides, T. 2002. Histone methylation in transcriptional control. Curr. Opin. Genet. Dev. 12:198-209.[CrossRef][Medline]
23. Laird, P. W., A. Zidjerveld, K. Linders, M. A. Rudnicki, R. Jaenisch, and A. Berns. 1991. Simplified mammalian DNA isolation procedure. Nucleic Acids Res. 19:4293.
24. Landry, J., A. Sutton, S. T. Tafrov, R. C. Heller, J. Stebbins, L. Pillus, and R. Sternglanz. 2000. The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases. Proc. Natl. Acad. Sci. USA 97:5807-5811.
25. Langley, E., M. Pearson, M. Faretta, U. M. Bauer, R. A. Frye, S. Minucci, P. G. Pelicci, and T. Kouzarides. 2002. Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO J. 21:2383-2396.[CrossRef][Medline]
26. Lau, S., K. Jardine, and M. W. McBurney. 1999. DNA methylation pattern of a tandemly repeated lacZ transgene indicates that most copies are silent. Dev. Dyn. 215:126-138.[CrossRef][Medline]
27. Lin, S. J., P. A. Defossez, and L. Guarente. 2000. Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science 289:2126-2128.
28. Liu, J. P., J. Baker, A. S. Perkins, E. J. Robertson, and A. Efstratiadis. 1993. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75:59-72.[Medline]
29. Luo, J., A. Y. Nikolaev, S. Imai, D. Chen, F. Su, A. Shiloh, L. Guarente, and W. Gu. 2001. Negative control of p53 by Sir2
promotes cell survival under stress. Cell 107:137-148.[CrossRef][Medline]
30. Lupton, S. D., L. L. Brunton, V. A. Kalberg, and R. W. Overell. 1991. Dominant positive and negative selection with a hygromycin phosphotransferase-thymidine kinase fusion gene. Mol. Cell. Biol. 11:3374-3378.
31. McBurney, M. W. 1999. Gene silencing in the development of cancer. Exp. Cell Res. 248:25-29.[CrossRef][Medline]
32. McBurney, M. W., W. A. Staines, K. Boekelheide, D. Parry, K. Jardine, and L. Pickavance. 1994. The murine Pgk-1 promoter drives widespread but not uniform expression in transgenic mice. Dev. Dyn. 200:278-293.[Medline]
33. Moazed, D. 2001. Common themes in mechanisms of gene silencing. Mol. Cell 8:489-498.[CrossRef][Medline]
34. Monget, P., and C. Bondy. 2000. Importance of the IGF system in early folliculogenesis. Mol. Cell. Endocrinol. 163:89-93.[CrossRef][Medline]
35. Mountford, P., B. Zevnik, A. Düwel, J. Nichols, M. Li, C. Dani, M. Robertson, I. Chambers, and A. Smith. 1994. Dicistronic targeting constructs: Reporters and modifiers of mammalian gene expression. Proc. Natl. Acad. Sci. USA 91:4303-4307.
36. Nagy, A., J. Rossant, R. Nagy, W. Abramow-Newerly, and J. C. Roder. 1993. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc. Natl. Acad. Sci. USA 90:8424-8428.
37. Powell-Braxton, L., P. Hollingshead, C. Warburton, M. Dowd, S. Pitts-Meek, D. Dalton, N. Gillett, and T. A. Stewart. 1993. IGF-I is required for normal embryonic growth in mice. Genes Dev. 7:2609-2617.
38. Prives, C., and J. L. Manley. 2001. Why is p53 acetylated? Cell 107:815-818.[CrossRef][Medline]
39. Richards, E. J., and S. C. Elgin. 2002. Epigenetic codes for heterochromatin formation and silencing: rounding up the usual suspects. Cell 108:489-500.[CrossRef][Medline]
40. Rosenberg, M. I., and S. M. Parkhurst. 2002. Drosophila Sir2 is required for heterchromatic silencing and by euchromatic hairy/E(Spl) bHLH repressors in segmentation and sex determination. Cell 109:447-458.[CrossRef][Medline]
41. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
42. Sherman, J. M., E. M. Stone, L. L. Freeman-Cook, C. B. Brachmann, J. D. Boeke, and L. Pillus. 1999. The conserved core of a human SIR2 homologue functions in yeast silencing. Mol. Biol. Cell 10:3045-3059.
43. Smith, J. S., C. B. Brachmann, I. Celic, M. A. Kenna, S. Muhammad, V. J. Starai, J. L. Avalos, J. C. Escalante-Semerena, C. Grubmeyer, C. Wolberger, and J. D. Boeke. 2000. A phylogenetically conserved NAD+-dependent protein deacetylase activity in the Sir2 protein family. Proc. Natl. Acad. Sci. USA 97:6658-6663.
44. Sterner, D. E., and S. L. Berger. 2000. Acetylation of histones and transcription-related factors. Microbiol. Mol. Biol. Rev. 64:435-459.
45. Tanny, J. C., and D. Moazed. 2001. Coupling of histone deacetylation to NAD breakdown by the yeast silencing protein Sir2: evidence for acetyl transfer from substrate to an NAD breakdown product. Proc. Natl. Acad. Sci. USA 98:415-420.
46. Tissenbaum, H. A., and L. Guarente. 2001. Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature 410:227-230.[CrossRef][Medline]
47. Tyl, R. W. 2002. Guidelines for mating rodents. Curr. Protocols Toxicol. Suppl. 11:162-210.